Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia

被引：9
|
作者：
Langabeer, Stephen E. [1 ]
McCarron, Sarah L.
Carroll, Peig
Kelly, Johanna [2 ]
O'Dwyer, Michael [3 ]
Conneally, Eibhlin [4 ]
机构：
[1] St James Hosp, Cent Pathol Lab, Dublin 8, Ireland
[2] Our Ladys Childrens Hosp, Natl Ctr Med Genet, Dublin, Ireland
[3] Natl Univ Ireland, Dept Haematol, Galway, Ireland
[4] St James Hosp, Dept Haematol, Dublin 8, Ireland
来源：
LEUKEMIA RESEARCH | 2011年 / 35卷 / 09期
关键词：
IMATINIB; MUTATION; DISEASE;
D O I：
10.1016/j.leukres.2011.05.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E169 / E170
页数：2
相关论文
共 50 条
  • [41] BCR-ABL1 b3a2 and b2a2 transcripts in chronic myeloid leukemia: does it matter?
    De Braekeleer, Marc
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (04) : 329 - 330
  • [42] Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia
    Radich, Jerald P.
    CANCER, 2012, 118 (02) : 300 - 311
  • [43] Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells
    Than, Hein
    Pomicter, Anthony D.
    Yan, Dongqing
    Beaver, Larry P.
    Eiring, Anna M.
    Heaton, William L.
    Senina, Anna
    Clair, Phillip M.
    Shacham, Sharon
    Mason, Clinton C.
    O'Hare, Thomas
    Deininger, Michael W.
    LEUKEMIA, 2020, 34 (06) : 1679 - 1683
  • [44] A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia
    Lyu, Xiaodong
    Yang, Jingke
    Wang, Xianwei
    Hu, Jieying
    Liu, Bing
    Zhao, Yu
    Guo, Zhen
    Liu, Bingshan
    Fan, Ruihua
    Song, Yongping
    MOLECULAR CYTOGENETICS, 2016, 9
  • [45] A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia
    Xiaodong Lyu
    Jingke Yang
    Xianwei Wang
    Jieying Hu
    Bing Liu
    Yu Zhao
    Zhen Guo
    Bingshan Liu
    Ruihua Fan
    Yongping Song
    Molecular Cytogenetics, 9
  • [46] A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia
    Garcia-Gutierrez, Valentin
    Gomez-Casares, Maria T.
    Puerta, Jose M.
    Alonso-Dominguez, Juan M.
    Osorio, Santiago
    Hernandez-Boiuda, Juan C.
    Collado, Rosa
    Ramirez, Maria J.
    Ibanez, Fatima
    Martin, Maria L.
    Rodriguez-Gambarte, Juan D.
    Martinez-Laperche, Carolina
    Gomez, Montse
    Fiallo, Dolly V.
    Redondo, Sara
    Rodriguez, Alicia
    Ruiz-Nuno, Concepcion
    Steegmann, Juan L.
    Jimenez-Velasco, Antonio
    PLOS ONE, 2017, 12 (03):
  • [47] MXD1 regulates the imatinib resistance of chronic myeloid leukemia cells by repressing BCR-ABL1 expression
    Chen Huan
    Lou Jin
    Wang Heng
    An Na
    Pan Yuming
    Du Xin
    Zhang Qiaoxia
    LEUKEMIA RESEARCH, 2018, 75 : 1 - 6
  • [48] Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia
    Kim, Yeojae
    Kim, Seongkoo
    Lee, Jong Mi
    Ahn, Ari
    Yoo, Jae Won
    Lee, Jae Wook
    Cho, Bin
    Chung, Nack-Gyun
    Kim, Yonggoo
    Kim, Myungshin
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [49] BCR-ABL1 p210 screening for chronic myeloid leukemia in patients with peripheral blood cytoses
    Fenu, Elena
    O'Neill, Stacey S.
    Insuasti-Beltran, Giovanni
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (06) : 1458 - 1464
  • [50] A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia
    Jin, Caibao
    Zhu, Xiaojian
    Xiao, Min
    Liu, Songya
    Liu, Xian
    Liu, Jingjing
    Xu, Xiuwen
    Yi, Shujuan
    Meng, Li
    ANNALS OF LABORATORY MEDICINE, 2018, 38 (02) : 169 - 171
12345